Natal teeth, intestinal pseudoobstruction and patent ductus
Other Names for this Disease
- Intestinal Pseudoobstruction with Patent Ductus Arteriosus and Natal Teeth
On this page
|Generic Name||Ibuprofen lysine|
The FDA has approved this product to be used in this manner.
|For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, et|
|More Information about this product||Drug Information Portal|